Share price close 16 Nov 2026
Quarterly or annual report filed
Quarterly or annual report filed
In one paragraph
ResMed| reported revenue of $5.65 billion for fiscal year 2026 (the twelve months to 30 Jun 2026), up 9.9% from fiscal 2025. Net income was $1.52 billion and diluted earnings per share $10.43.
In its latest reported quarter, the first quarter of fiscal 2027 (the three months to 30 Sep 2026), revenue was $1.41 billion, up 5.9% from a year earlier.
Figures from ResMed|'s annual and quarterly reports, compiled and checked by AapWire. Latest report filed 30 Oct 2026.
Fiscal 2026 against fiscal 2025; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.
| Segment | Revenue | Share | Change |
|---|---|---|---|
| Total Sleep and Breathing Health | $4.98B | 88% | +10.5% |
| Residential Care Software | $675.8M | 12% | +5.4% |
ResMed| beside the other S&P 500 members in Health Care Equipment, by market value.
| Company | Market value | Day | 1 year | Revenue growth | Net margin | P/E |
|---|---|---|---|---|---|---|
| — | +0.3% | −5.3% | — | — | — | |
| $188.1B | +1.2% | −15.8% | +10.0% | 9.7% | 40.0 | |
| Intuitive SurgicalISRG | $152.6B | +0.8% | −22.5% | +20.5% | 25.5% | 51.6 |
| $63.86B | +0.3% | −57.4% | +8.9% | 16.6% | 18.2 | |
| $61.47B | +1.3% | +25.2% | +13.4% | 15.3% | 60.2 | |
| $59.14B | +1.1% | +44.4% | −2.6% | 4.5% | 62.9 | |
| $55.78B | +0.9% | −1.3% | +11.9% | 25.4% | 47.2 |
Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.
Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.
| Revenue | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| Total Sleep and Breathing Health | $3.18B | $3.73B+17.2% | $4.10B+10.1% | $4.50B+9.8% | $4.98B+10.5% |
| Residential Care Software | $400.8M | $498.0M+24.2% | $584.1M+17.3% | $641.4M+9.8% | $675.8M+5.4% |
| Total revenue | $3.58B | $4.22B | $4.69B | $5.15B | $5.65B |
| Revenue | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| Total Sleep and Breathing Health | $3.18B | $3.73B+17.2% | $4.10B+10.1% | $4.50B+9.8% | $4.98B+10.5% |
| Residential Care Software | $400.8M | $498.0M+24.2% | $584.1M+17.3% | $641.4M+9.8% | $675.8M+5.4% |
| Total revenue | $3.58B | $4.22B | $4.69B | $5.15B | $5.65B |
| Revenue | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| United States | $2.25B | $2.72B+20.9% | $2.98B+9.6% | $3.29B+10.3% | $3.56B+8.4% |
| Rest of the World | $1.33B | $1.50B+13.1% | $1.71B+13.5% | $1.86B+9.1% | $2.09B+12.4% |
| Total revenue | $3.58B | $4.22B | $4.69B | $5.15B | $5.65B |
Fiscal years, the latest ending 30 Jun 2026. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.
| Period | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.07B | $2.34B | $2.61B | $2.96B | $3.20B | $3.58B | $4.22B | $4.69B | $5.15B | $5.65B |
| Revenue growth | +12.4% | +13.2% | +11.4% | +13.4% | +8.1% | +11.9% | +18.0% | +10.9% | +9.8% | +9.9% |
| Gross profit | $1.20B | $1.33B | $1.49B | $1.72B | $1.84B | $2.02B | $2.36B | $2.66B | $3.05B | $3.45B |
| Operating income | $425.8M | $541.8M | $579.3M | $809.7M | $903.7M | $1.00B | $1.13B | $1.32B | $1.69B | $1.89B |
| Net income | $342.3M | $315.6M | $404.6M | $621.7M | $474.5M | $779.4M | $897.6M | $1.02B | $1.40B | $1.52B |
| Diluted EPS | $2.40 | $2.19 | $2.80 | $4.27 | $3.24 | $5.30 | $6.09 | $6.92 | $9.51 | $10.43 |
| Gross margin | 58.1% | 57.0% | 57.3% | 58.1% | 57.5% | 56.6% | 55.8% | 56.7% | 59.4% | 61.1% |
| Operating margin | 20.6% | 23.2% | 22.2% | 27.4% | 28.3% | 28.0% | 26.8% | 28.2% | 32.7% | 33.4% |
| Net margin | 16.6% | 13.5% | 15.5% | 21.0% | 14.8% | 21.8% | 21.3% | 21.8% | 27.2% | 26.9% |
| Period | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $414.1M | $505.0M | $459.1M | $802.3M | $736.7M | $351.1M | $693.3M | $1.40B | $1.75B | $1.81B |
| Capital expenditure | $62.22M | $62.58M | $68.71M | $95.33M | $102.7M | $134.8M | $119.7M | $99.46M | $89.86M | $156.3M |
| Free cash flow | $351.8M | $442.4M | $390.3M | $706.9M | $634.0M | $216.3M | $573.6M | $1.30B | $1.66B | $1.65B |
| Period | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $821.9M | $188.7M | $147.1M | $463.2M | $295.3M | $273.7M | $227.9M | $238.4M | $1.21B | $1.47B |
| Total debt | $1.08B | $281.5M | $1.27B | $1.30B | $793.7M | $917.5M | $1.58B | $873.9M | $851.8M | $825.9M |
| Shareholders' equity | $1.96B | $2.06B | $2.07B | $2.50B | $2.89B | $3.36B | $4.13B | $4.86B | $5.97B | $6.59B |
| Diluted shares | 142M | 144M | 144M | 146M | 146M | 147M | 147M | 148M | 147M | 146M |
| Dividends per share | $1.32 | $1.40 | $1.48 | $1.56 | $1.56 | $1.68 | $1.76 | $1.92 | $2.12 | $2.40 |
The last eight fiscal quarters, the latest ending 30 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.
| Period | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.28B | $1.29B | $1.35B | $1.34B | $1.42B | $1.43B | $1.46B | $1.41B |
| Revenue, year on year | +10.3% | +7.9% | +10.2% | +9.1% | +11.0% | +10.8% | +8.6% | +5.9% |
| Gross margin | 58.6% | 59.3% | 60.8% | 61.2% | 61.8% | 62.2% | 58.8% | 61.5% |
| Operating income | $417.2M | $426.3M | $454.5M | $446.5M | $491.7M | $499.8M | $448.7M | $453.0M |
| Net income | $344.6M | $365.0M | $379.7M | $348.5M | $392.6M | $398.7M | $383.4M | $418.4M |
| Diluted EPS | $2.34 | $2.48 | $2.58 | $2.37 | $2.68 | $2.74 | $2.64 | $2.92 |
| Free cash flow | $288.0M | $557.9M | $508.2M | $414.4M | $311.2M | $520.5M | $403.5M | $373.7M |
The operating figures ResMed| reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.
| KPI | Latest | Period | Change on a year | Recent periods |
|---|---|---|---|---|
| Devices revenue | $288.2M | quarter to 31 Mar 2026 | up 13.7% | |
| Masks and other revenue | $153.6M | quarter to 31 Mar 2026 | up 20.3% | |
| Residential Care Software revenue | $155.0M | quarter to 30 Sep 2026 | down 6.7% | |
| United States revenue | $3.6B | fiscal year to 30 Jun 2026 | up 8.4% | |
| Rest of the World revenue | $2.1B | fiscal year to 30 Jun 2026 | up 12.4% | |
| Global revenue | $1.4B | quarter to 31 Mar 2026 | up 10.8% | |
| U.S., Canada and Latin America revenue | $818.7M | quarter to 31 Mar 2026 | up 9.3% | |
| Combined Europe, Asia and other markets revenue | $441.8M | quarter to 31 Mar 2026 | up 15.9% |
Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.
The same figures as plain text and JSON.
$5.65 billion for fiscal year 2026 (the twelve months to 30 Jun 2026), as reported in its annual report.
$1.52 billion for fiscal year 2026 (the twelve months to 30 Jun 2026).
$10.43 for fiscal year 2026 (the twelve months to 30 Jun 2026).
61.1% for fiscal year 2026 (the twelve months to 30 Jun 2026): gross profit divided by revenue.
33.4% for fiscal year 2026 (the twelve months to 30 Jun 2026): operating income divided by revenue.
$1.65 billion for fiscal year 2026 (the twelve months to 30 Jun 2026): operating cash flow less capital expenditure.
In fiscal 2026, by segment: Total Sleep and Breathing Health $4.98B (88%), Residential Care Software $675.8M (12%), out of $5.65B in all, as stated in its annual report.
In the terminal